SCHEMBL14224359

SCHEMBL14224359

OCCN1CCN(CCCOc2cccc(Nc3nccc(-c4cnc(-c5cccc(Oc6ccccc6)c5)[nH]4)n3)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AIMP2 Q13155 1/20 0.48
SYK P43405 7/20 0.45
SRC P12931 2/20 0.44
EGFR P00533 2/20 0.44
ABL1 P00519 2/20 0.44
BCR P11274 2/20 0.44
PRKCA P17252 1/20 0.44
PRKCD Q05655 1/20 0.44
JAK2 O60674 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CACNA1B Q00975 2/20 0.40
ERBB2 P04626 2/20 0.39
PTK6 Q13882 2/20 0.39
GSK3B P49841 1/20 0.39
PDGFRB P09619 1/20 0.39
INSR P06213 1/20 0.39
IGF1R P08069 1/20 0.39
MET P08581 1/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14224086 0.94 AIMP2 (0.49) AIMP2SYKSRCEGFRABL1
SCHEMBL14224075 0.93 AIMP2 (0.48) AIMP2SYKSRCEGFRABL1
SCHEMBL14224093 0.93 SYK (0.49) AIMP2SYKSRCEGFRABL1
SCHEMBL14224140 0.93 AIMP2 (0.50) AIMP2SYKSRCEGFRABL1
SCHEMBL14195967 0.92 AIMP2 (0.51) AIMP2SYKSRCEGFRABL1
SCHEMBL14224454 0.92 AIMP2 (0.47) AIMP2SYKSRCEGFRABL1
SCHEMBL14224074 0.91 AIMP2 (0.44) AIMP2SYKSRCEGFRABL1
SCHEMBL14224273 0.91 AIMP2 (0.45) AIMP2SYKSRCEGFRABL1
SCHEMBL14224076 0.91 ABL1 (0.49) AIMP2SYKSRCEGFRABL1
SCHEMBL14224455 0.91 SYK (0.47) AIMP2SYKSRCEGFRABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7361665-B2 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-22 US disclosed